Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen
- 1 May 2004
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 26 (5) , 724-736
- https://doi.org/10.1016/s0149-2918(04)90072-0
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk
This publication has 22 references indexed in Scilit:
- ErrataDiabetes Care, 2003
- Standards of Medical Care for Patients With Diabetes MellitusDiabetes Care, 2003
- Variability of Insulin Absorption and Insulin ActionDiabetes Technology & Therapeutics, 2002
- Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pensThe Lancet, 1999
- Mechanism of protracted metabolic effects of fatty acid acylated insulin, NN304, in dogs: retention of NN304 by albuminDiabetologia, 1999
- The Absence of a Glycemic Threshold for the Development of Long-Term Complications: The Perspective of the Diabetes Control and Complications TrialDiabetes, 1996
- Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigsDiabetologia, 1996
- Improving Insulin Therapy: Achievements and ChallengesHormone and Metabolic Research, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes MellitusNew England Journal of Medicine, 1993